Ogenix

Ogenix is a medical technology company specializing in advanced wound care solutions through the delivery of continuous oxygen therapy. The company's primary product, Epiflo, is a portable, wearable device that provides Transdermal Continuous Oxygen Therapy (TCOT) directly to chronic wounds. This treatment modality is designed to stimulate healing in stagnant or non-responsive wounds, such as diabetic foot ulcers and pressure sores, by maintaining a high concentration of oxygen at the wound bed. Ogenix focuses on providing cost-effective, home-based alternatives to traditional hyperbaric oxygen therapy, significantly improving patient mobility and compliance. The Epiflo device is FDA-cleared and intended for use in both clinical and home settings.